Lyka Labs Limited (NSE: LYKALABS), ISIN INE933A01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
LYKALABS last traded at ₹59.85 (-3.44%), with a 52-week range of ₹44.49 to ₹121.00 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 58.16%, FIIs 0.29%, DIIs 0.67%, mutual funds 0.01%.
EquiSense Score (ECS): 21/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.